Could cannabis terpene formulation treat COVID-19?
Posted On April 27, 2020
- A unique formulation of cannabis terpenes is being tested for its efficacy in treating viral infections, including COVID-19.
- In previous research, undertaken since the outbreak of the SARS virus in 2002, cannabis terpenes have been found to be effective potential antiviral agents, and specific terpenes that come into contact with the SARS virus were found to reduce its severity and impact (both in-vitro and in-vivo ) by withholding a certain protein that replicates the RNA preventing it from penetrating healthy cells and using them as hosts for its replication.
- The novel formulation is designed to be consumed by direct inhalation.
Read full article: healtheuropa.eu